The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Exact Sciences Corp. is dismissing Ernst & Young as its independent accounting firm.
Officials at the Marlborough-based molecular diagnostics maker, which is developing tests for colorectal cancer, said the company would retain Grant Thornton LLP instead, according to a filing with the federal Securities and Exchange Commission.
Angus McQuilken, VP for Communications, Massachusetts Life Sciences Center
The 2009 BIO International Convention opened today in Atlanta at the Georgia World Congress Center with a series of panel discussions, but the real action is on the exhibit floor, where construction is under way of exhibition pavilions for hundreds of companies, along with state and national governments.
The Massachusetts Pavilion is nearly ready for the opening of the show floor tomorrow morning at 10:15. The Pavilion theme for Massachusetts is “The Big Bang: Massachusetts Life Sciences Supercluster.”
Former Boston Scientific Corp. COO Paul LaViolette was elected to the board of directors of Thoratec Corp. at its May 13 annual shareholders meeting.
LaViolette rose from senior vice president and group president of several divisions to become the Natick device giant’s chief operating officer in 2004.
Pleasanton, Calif.-based Thoratec, which has operations in Burlington, develops devices to treat advanced-stage heart failure, point-of-care blood testing and skin incision products.
Abiomed Inc. predicted revenue growth of up to 25 percent for fiscal 2010, as the Danvers-based company looks to increase the footprint of its catheter-based cardiac assist devices and cash in on some regulatory victories.
The Impella 2.5 catheter-based cardiac assist device, which removes congestion from the left ventricle, accounted for nearly half of Abiomed’s fourth-quarter sales worldwide.
Omniguide Inc. raised $1.8 million in equity financing, almost a year to the day from a previous $25 million private equity round.
The Cambridge-based flexible laser scalpel maker reported selling an undisclosed amount of equity to an unnamed investor or investors for $1.84 million.
Omniguide makes a small, flexible laser scalpel, the BeamPath CO2 laser energy system, which can be used in during procedures in difficult-to-reach portions of the human body, such as surgery to remove tumors from the throat.
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
{IMAGERIGHT:http://www.massdevice.com/sites/default/files/checkup/090519_index.gif}Our Weekly Checkup takes the temperature of the 63 public medical device companies in the MassDevice Index. The index is weighted according to market capitalization, based on the number of shares outstanding for each company from its most recent quarterly report and each Friday’s closing share price.
Osmetech Inc. asked the Food & Drug Administration for emergency approval to use its Respiratory Pathogen Test Panel to screen for the Swine Flu.
The London-based molecular diagnostics maker, which has operations in Maynard, is the latest company to enter the H1N1 virus diagnostics race.
Inverness Medical Innovations Inc. first told the Centers for Disease Control that it stood ready to supply point-of-care tests for the virus.
Aspect Medical Systems Inc. inked a multi-year, international licensing agreement with the German affiliate of Philips Healthcare for worldwide distribution of its line of anesthesia sensors.
Philips Medizin Systeme GmbH will purchase and distribute the Norwood-based company’s BISx kits, BIS sensors and peripherals for at least three years. The contract also has two one-year automatic renewals written into it. Other terms of the deal were not disclosed.
Reform: The other Massachusetts health plan
Legislation on the floor by the end of July: That’s what Nancy Pelosi said Wednesday after she and key House committee heads met with President Barack Obama.
“This is about costs” she said.
Obama’s word: “Unsustainable.”
But fixes to the way we pay for health care will move a lot of money around. There will be winners and losers. It will get ugly. Still, there is serious momentum.
Some of that could be seen during the last of three Senate Finance Committee meetings on the reform bill. The Tuesday video is still up on C-Span.
A Worcester Polytechnic Institute professor is headed to Ireland for a year to study nanoscale tissue engineering, thanks to a federal Fulbright Scholarship.
Kristen Billiar, an associate professor of biomedical engineering at WPI, is the 14th faculty member to land the award and the school’s first in the life sciences. He’ll spend the 2009-2010 academic year at the National University of Ireland, Galway, working with that school’s Abhay Pandit on the study of the mechanics of nanoscale scaffolds for tissue engineering.
